Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to -$1.4 million.

  • Integra Lifesciences Holdings' Tax Provisions rose 8531.09% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.9 million, marking a year-over-year decrease of 82904.19%. This contributed to the annual value of -$11.3 million for FY2024, which is 18473.14% down from last year.
  • Integra Lifesciences Holdings' Tax Provisions amounted to -$1.4 million in Q3 2025, which was up 8531.09% from -$46.9 million recorded in Q2 2025.
  • Integra Lifesciences Holdings' Tax Provisions' 5-year high stood at $21.9 million during Q1 2021, with a 5-year trough of -$46.9 million in Q2 2025.
  • Over the past 5 years, Integra Lifesciences Holdings' median Tax Provisions value was $5.6 million (recorded in 2023), while the average stood at $1.5 million.
  • In the last 5 years, Integra Lifesciences Holdings' Tax Provisions surged by 86746.24% in 2021 and then crashed by 158447.72% in 2025.
  • Integra Lifesciences Holdings' Tax Provisions (Quarter) stood at $6.4 million in 2021, then surged by 75.89% to $11.3 million in 2022, then decreased by 19.87% to $9.0 million in 2023, then plummeted by 65.58% to $3.1 million in 2024, then plummeted by 145.72% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, -$46.9 million for Q2 2025, and -$4.7 million during Q1 2025.